Honghai Wu - Publications, H-index & Citations

Honghai Wu

Henan University of Science and Technology

24H指数

112论文数

1.9K被引数

收录论文 44

发表时间

Identification of flavonoid-based small molecule inhibitors with dual-targeting capability against RdRp and Mpro of SARS-CoV-2 鉴定具有双靶点能力的黄酮类小分子抑制剂，针对SARS-CoV-2的RdRp和Mpro

Bioorganic & Medicinal Chemistry Letters

IF2.2

2025-12-08

PREAI

Yanlei Su; Yujia Wang; Jianyuan Zhao; Keyu Guo; Xuhong Duan; Honghai Wu; Dianxing Sun; Jing Zhang; Shan Cen

Association between arthritis and urinary incontinence in US adults: A cross-sectional study based on NHANES 2011-2023 关节炎与尿失禁在美国成年人中的关联：一项基于NHANES 2011-2023的横断面研究

MEDICINE

IF1.4

2025-11-14

PREAI

Yan, Cheng; Wu, Hong-hai; Liu, Ting-ting; Zhang, Hu; Li, Fang-long; Zhang, Xiao-gang

Digital twin traffic flow prediction based on graph federated learning in intelligent IoT 基于图联邦学习在智能物联网中的数字孪生交通流预测

China Communications

IF3.1

2025-07-01

PREAI

Li Bing; Gao Jianping; Xing Ling; Wu Honghai; Ma Huahong; Zhang Xiaohui

Selective BCL-2 inhibitor triggers STING-dependent antitumor immunity via inducing mtDNA release 选择性BCL-2抑制剂通过诱导mtDNA释放触发STING依赖性的抗肿瘤免疫。

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2025-04-29

OAAI

Zhang, Wenxin; Pan, Xiaohui; Wang, Longsheng; Li, Wen; Dai, Xiaoyang; Zheng, Mingming; Guo, Hongjie; Chen, Xi; Xu, Yanjun; Wu, Honghai; He, Qiaojun; Yang, Bo; Ding, Ling

IMPDH inhibitors upregulate PD-L1 in cancer cells without impairing immune checkpoint inhibitor efficacy

ACTA PHARMACOLOGICA SINICA

IF8.4

2024-11-26

PREAI

Zheng, Ming-ming; Li, Jia-yi; Guo, Hong-jie; Zhang, Jie; Wang, Long-sheng; Jiang, Ke-fan; Wu, Hong-hai; He, Qiao-jun; Ding, Ling; Yang, Bo

Zosuquidar Promotes Antitumor Immunity by Inducing Autophagic Degradation of PD-L1 Zosuquidar通过诱导PD-L1的自噬降解促进抗肿瘤免疫

ADVANCED SCIENCE

IF14.1

2024-09-04

OAAI

Ding, Ling; Guo, Hongjie; Zhang, Jie; Zheng, Mingming; Zhang, Wenjie; Wang, Longsheng; Du, Qianqian; Zhou, Chen; Xu, Yanjun; Wu, Honghai; He, Qiaojun; Yang, Bo

Cediranib enhances the transcription of MHC-I by upregulating IRF-1 西地尼布通过上调IRF-1增强mhc-i的转录

BIOCHEMICAL PHARMACOLOGY

IF5.6

2024-03-01

OAAI

Zhang, Jie; Guo, Hongjie; Wang, Longsheng; Zheng, Mingming; Kong, Shijia; Wu, Honghai; Zhao, Lin; Zhao, Qiong; Yang, Xiaochun; He, Qiaojun; Chen, Xi; Ding, Ling; Yang, Bo

Insights into the role of derailed endocytic trafficking pathway in cancer: From the perspective of cancer hallmarks

PHARMACOLOGICAL RESEARCH

IF10.5

2024-03-01

OAAI

Guo, Hongjie; Zhou, Chen; Zheng, Mingming; Zhang, Jie; Wu, Honghai; He, Qiaojun; Ding, Ling; Yang, Bo

Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA (vol 13, 4337, 2023)

ACTA PHARMACEUTICA SINICA B

IF14.6

2023-10-01

OAAI

Zhang, Wenxin; Pan, Xiaohui; Xu, Yanjun; Guo, Hongjie; Zheng, Mingming; Chen, Xi; Wu, Honghai; Luan, Fengming; He, Qiaojun; Ding, Ling; Yang, Bo

Physiologically-based pharmacokinetic modeling for optimal dosage prediction of olaparib when co-administered with CYP3A4 modulators and in patients with hepatic/renal impairment

SCIENTIFIC REPORTS

IF3.9

2023-09-25

OAAI

Gao, Dongmei; Wang, Guopeng; Wu, Honghai; Ren, Jiawei

KLF12 transcriptionally regulates PD-L1 expression in non-small cell lung cancer

MOLECULAR ONCOLOGY

IF4.5

2023-09-02

OAAI

Pan, Xiaohui; Zhang, Wenxin; Wang, Longsheng; Guo, Hongjie; Zheng, Mingming; Wu, Honghai; Weng, Qinjie; He, Qiaojun; Ding, Ling; Yang, Bo

Strategies to synergize PD-1/PD-L1 targeted cancer immunotherapies to enhance antitumor responses in ovarian cancer 协同PD-1/PD-L1靶向癌症免疫疗法以增强卵巢癌抗肿瘤反应的策略

BIOCHEMICAL PHARMACOLOGY

IF5.6

2023-09-01

PREAI

Zhao, Lin; Chen, Xi; Wu, Honghai; He, Qiaojun; Ding, Ling; Yang, Bo

Strategies involving STING pathway activation for cancer immunotherapy: Mechanism and agonists 涉及STING通路激活的癌症免疫治疗策略: 机制和激动剂

BIOCHEMICAL PHARMACOLOGY

IF5.6

2023-07-01

PREAI

Pan, Xiaohui; Zhang, Wenxin; Guo, Hongjie; Wang, Longsheng; Wu, Honghai; Ding, Ling; Yang, Bo

Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA

ACTA PHARMACEUTICA SINICA B

IF14.6

2023-06-01

OAAI

Zhang, Wenxin; Pan, Xiaohui; Xu, Yanjun; Guo, Hongjie; Zheng, Mingming; Chen, Xi; Wu, Honghai; Luan, Fengming; He, Qiaojun; Ding, Ling; Yang, Bo

Prediction for Plasma Trough Concentration and Optimal Dosing of Imatinib under Multiple Clinical Situations Using Physiologically Based Pharmacokinetic Modeling

ACS OMEGA

IF4.3

2023-04-03

OAAI

Gao, Dongmei; Wang, Guopeng; Wu, Honghai; Wu, JinHua; Zhao, Xiaoang

The impact of lipids on the cancer-immunity cycle and strategies for modulating lipid metabolism to improve cancer immunotherapy

ACTA PHARMACEUTICA SINICA B

IF14.6

2023-04-01

OAAI

Zheng, Mingming; Zhang, Wenxin; Chen, Xi; Guo, Hongjie; Wu, Honghai; Xu, Yanjun; He, Qiaojun; Ding, Ling; Yang, Bo

Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2023-01-03

OAAI

Ding, Ling; Chen, Xi; Zhang, Wenxin; Dai, Xiaoyang; Guo, Hongjie; Pan, Xiaohui; Xu, Yanjun; Feng, Jianguo; Yuan, Meng; Gao, Xiaomeng; Wang, Jian; Xu, Xiaqing; Li, Sicheng; Wu, Honghai; Cao, Ji; He, Qiaojun; Yang, Bo

Butein suppresses PD-L1 expression via downregulating STAT1 in non-small cell lung cancer

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2023-01-01

OAAI

Zhao, Lin; Zhang, Wenxin; Luan, Fengming; Chen, Xi; Wu, Honghai; He, Qiaojun; Weng, Qinjie; Ding, Ling; Yang, Bo

Progesterone Suppresses Cholesterol Esterification in APP/PS1 mice and a cell model of Alzheimer's Disease

BRAIN RESEARCH BULLETIN

IF3.7

2021-08-01

PREAI

Shi, Wenjing; Wu, Hang; Liu, Sha; Wu, Zhigang; Wu, Honghai; Liu, Jianfang; Hou, Yanning